137 related articles for article (PubMed ID: 32971087)
1. The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors.
Gorka J; Marona P; Kwapisz O; Rys J; Jura J; Miekus K
Eur J Pharmacol; 2020 Dec; 888():173591. PubMed ID: 32971087
[TBL] [Abstract][Full Text] [Related]
2. MCPIP1 contributes to clear cell renal cell carcinomas development.
Ligeza J; Marona P; Gach N; Lipert B; Miekus K; Wilk W; Jaszczynski J; Stelmach A; Loboda A; Dulak J; Branicki W; Rys J; Jura J
Angiogenesis; 2017 Aug; 20(3):325-340. PubMed ID: 28197812
[TBL] [Abstract][Full Text] [Related]
3. MCPIP1 regulates focal adhesion kinase and Rho GTPase-dependent migration in clear cell renal cell carcinoma.
Gorka J; Marona P; Kwapisz O; Rys J; Jura J; Miekus K
Eur J Pharmacol; 2022 May; 922():174804. PubMed ID: 35257717
[TBL] [Abstract][Full Text] [Related]
4. MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression.
Marona P; Górka J; Mazurek Z; Wilk W; Rys J; Majka M; Jura J; Miekus K
Cancer Res; 2017 Sep; 77(18):4905-4920. PubMed ID: 28716897
[TBL] [Abstract][Full Text] [Related]
5. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
[TBL] [Abstract][Full Text] [Related]
6. Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.
Marona P; Górka J; Kwapisz O; Jura J; Rys J; Hoffman RM; Miekus K
Cell Death Dis; 2022 Sep; 13(9):814. PubMed ID: 36138026
[TBL] [Abstract][Full Text] [Related]
7. MCPIP1 inhibits Hepatitis B virus replication by destabilizing viral RNA and negatively regulates the virus-induced innate inflammatory responses.
Li M; Yang J; Zhao Y; Song Y; Yin S; Guo J; Zhang H; Wang K; Wei L; Li S; Xu W
Antiviral Res; 2020 Feb; 174():104705. PubMed ID: 31926181
[TBL] [Abstract][Full Text] [Related]
8. MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma.
Boratyn E; Nowak I; Durbas M; Horwacik I; Sawicka A; Rokita H
J Cell Biochem; 2017 Jul; 118(7):1741-1755. PubMed ID: 27935099
[TBL] [Abstract][Full Text] [Related]
9. MCPIP1 contributes to the inflammatory response of UVB-treated keratinocytes.
Bugara B; Konieczny P; Wolnicka-Glubisz A; Eckhart L; Fischer H; Skalniak L; Borowczyk-Michalowska J; Drukala J; Jura J
J Dermatol Sci; 2017 Jul; 87(1):10-18. PubMed ID: 28377026
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes.
Makki MS; Haqqi TM
Connect Tissue Res; 2017 Jan; 58(1):64-75. PubMed ID: 27404795
[TBL] [Abstract][Full Text] [Related]
11. MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation.
Garg AV; Amatya N; Chen K; Cruz JA; Grover P; Whibley N; Conti HR; Hernandez Mir G; Sirakova T; Childs EC; Smithgall TE; Biswas PS; Kolls JK; McGeachy MJ; Kolattukudy PE; Gaffen SL
Immunity; 2015 Sep; 43(3):475-87. PubMed ID: 26320658
[TBL] [Abstract][Full Text] [Related]
12. Ectopic overexpression of MCPIP1 impairs adipogenesis by modulating microRNAs.
Losko M; Lichawska-Cieslar A; Kulecka M; Paziewska A; Rumienczyk I; Mikula M; Jura J
Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):186-195. PubMed ID: 28939056
[TBL] [Abstract][Full Text] [Related]
13. Activity of MCPIP1 RNase in tumor associated processes.
Miekus K; Kotlinowski J; Lichawska-Cieslar A; Rys J; Jura J
J Exp Clin Cancer Res; 2019 Oct; 38(1):421. PubMed ID: 31639017
[TBL] [Abstract][Full Text] [Related]
14. Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin.
Bakhtyar N; Wong N; Kapoor A; Cutz JC; Hill B; Ghert M; Tang D
Eur J Cancer; 2013 Nov; 49(16):3537-46. PubMed ID: 23896380
[TBL] [Abstract][Full Text] [Related]
15. MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses.
Lin RJ; Chu JS; Chien HL; Tseng CH; Ko PC; Mei YY; Tang WC; Kao YT; Cheng HY; Liang YC; Lin SY
J Immunol; 2014 Oct; 193(8):4159-68. PubMed ID: 25225661
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function.
Oh YT; Qian G; Deng J; Sun SY
Oncogene; 2018 Jun; 37(25):3415-3425. PubMed ID: 29551769
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein-induced protein 1 impairs adipogenesis in 3T3-L1 cells.
Lipert B; Wegrzyn P; Sell H; Eckel J; Winiarski M; Budzynski A; Matlok M; Kotlinowski J; Ramage L; Malecki M; Wilk W; Mitus J; Jura J
Biochim Biophys Acta; 2014 Apr; 1843(4):780-8. PubMed ID: 24418043
[TBL] [Abstract][Full Text] [Related]
18. p38 but not p53 is responsible for UVA-induced MCPIP1 expression.
Skalniak L; Smejda M; Cierniak A; Adamczyk A; Konieczny P; Madej E; Wolnicka-Glubisz A
Mech Ageing Dev; 2018 Jun; 172():96-106. PubMed ID: 29103983
[TBL] [Abstract][Full Text] [Related]
19. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
20. MCPIP1 functions as a safeguard of early embryonic development.
Lichawska-Cieslar A; Szukala W; Prajsnar TK; Pooranachandran N; Kulecka M; Dabrowska M; Mikula M; Rakus K; Chadzinska M; Jura J
Sci Rep; 2023 Oct; 13(1):16944. PubMed ID: 37805647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
